Medicare Enrolled
Dr. Mitchell Mandel, M.D.
Dermatopathology Physician · New York, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mandel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mandel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mandel
Dr. Mitchell Mandel is a dermatopathology physician in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mandel performed 4,560 Medicare services across 2,630 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mandel received a total of $11,535 from 45 pharmaceutical and/or device companies across 422 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mandel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ 4,560 Medicare services
$11,535 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,560
Medicare services
Bottom 48% in NY for dermatopathology physician
2,630
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~240 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,061 | $6 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
993 | $77 | $350 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
590 | $88 | $386 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
338 | $54 | $300 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
289 | $46 | $198 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
246 | $113 | $500 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
173 | $89 | $450 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
173 | $1 | $50 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
167 | $143 | $950 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
92 | $100 | $650 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
90 | $47 | $250 |
| Injection into skin growths, more than 7 A procedure involving the injection of medication into more than seven skin growths. |
69 | $59 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $139 | $650 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
48 | $146 | $700 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $44 | $250 |
| Acne surgery A surgical procedure to treat acne. The specific techniques and extent of the surgery are not defined in this general code description. |
32 | $103 | $435 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
26 | $100 | $600 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
23 | $105 | $488 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
21 | $267 | $1,250 |
| Punch biopsy of additional skin growth A small circular tool is used to remove a sample of an extra skin growth for laboratory examination. |
14 | $56 | $229 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
12 | $124 | $1,000 |
| Removal of noncancer skin growth, 0.6-1.0 cm This procedure involves the removal of a benign skin growth located on the body, arms, or legs. The growth removed measures between 0.6 and 1.0 centimeters in diameter. |
11 | $129 | $600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
27.4% medium
71.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,535
Total received (2018-2024)
Avg $1,648/year across 7 years
Top 25% in NY for dermatopathology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
422
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,294 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$241 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,032
2023
$1,741
2022
$1,544
2021
$793
2020
$357
2019
$1,896
2018
$1,171
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
MERZ NORTH AMERICA, INC.
$1,194
Arcutis Biotherapeutics, Inc.
$680
REVANCE THERAPEUTICS, INC.
$467
Janssen Biotech, Inc.
$458
PFIZER INC.
$256
Dermavant Sciences, Inc.
$203
ABBVIE INC.
$199
Incyte Corporation
$180
Lilly USA, LLC
$82
Novartis Pharmaceuticals Corporation
$74
Amgen Inc.
$69
Verrica Pharmaceuticals Inc.
$48
SUN PHARMACEUTICAL INDUSTRIES INC.
$41
UCB, Inc.
$32
GENZYME CORPORATION
$29
Biofrontera Inc.
$20
Top 3 companies account for 58.1% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$1,384
Janssen Biotech, Inc.
$1,226
MERZ NORTH AMERICA, INC.
$1,194
Lilly USA, LLC
$946
Merz North America, Inc.
$935
Arcutis Biotherapeutics, Inc.
$680
AbbVie, Inc.
$603
Galderma Laboratories, L.P.
$570
REVANCE THERAPEUTICS, INC.
$467
Novartis Pharmaceuticals Corporation
$423
Dermavant Sciences, Inc.
$407
Incyte Corporation
$307
ABBVIE INC.
$300
Almirall LLC
$261
Amgen Inc.
$256
GENZYME CORPORATION
$164
Sun Pharmaceutical Industries Inc.
$146
Janssen Scientific Affairs, LLC
$124
Celgene Corporation
$104
LEO Pharma Inc.
$100
STRATA Skin Sciences, Inc.
$90
AbbVie Inc.
$85
Biofrontera Inc.
$80
UCB, Inc.
$78
Ortho Dermatologics, a division of Bausch Health US, LLC
$70
kaleo, Inc.
$64
Regeneron Healthcare Solutions, Inc.
$51
Verrica Pharmaceuticals Inc.
$48
SUN PHARMACEUTICAL INDUSTRIES INC.
$41
Journey Medical Corporation
$40
Mission Pharmacal Company
$39
Mayne Pharma Inc.
$34
DUSA Pharmaceuticals, Inc.
$23
PruGen, Inc. Pharmaceuticals
$23
DERMIRA, INC.
$21
Encore Dermatology Inc.
$18
MEDLINE INDUSTRIES LP
$17
Aclaris Therapeutics, Inc.
$17
Solta Medical, a division of Bausch Health US, LLC
$16
Allergan, Inc.
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Allegis Pharmaceuticals, LLC
$14
EPI Health, LLC
$14
Mylan Pharmaceuticals Inc.
$14
Pierre Fabre Pharmaceuticals, Inc.
$11
Top 3 companies account for 33.0% of all-time payments
Associated products mentioned in payments ›
20% · AKLIEF · ALTRENO · AMELUZ · AUVI-Q · Aczone · Ameluz · Avar · Bimzelx · CIBINQO · COSENTYX · CYLTEZO · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · Cordran · DAXXIFY · DORYX · DUPIXENT · Dermatological Psoriasis and Vitiligo Treatment · EBGLYSS · EFUDEX · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · HUMIRA · Humira · ILUMYA · Impoyz · Klisyri · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · OLUMIANT · OPZELURA · Otezla · PICATO · QBREXZA · REMICADE · RHOFADE · RINVOQ · SKYRIZI · SOOLANTRA · SPINOSAD · Seysara · Skyrizi · TALTZ · TREMFYA · Tremfya · VTAMA · WYNZORA · Winlevi · XEOMIN · XTRAC · Xeomin · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Dermatopathology physicians within 10 mi
30
Per 100K population
1.8
County median income
$104,553
Nearest hospital
NEW YORK-PRESBYTERIAN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mandel is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mandel experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Mandel performed 1,061 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mandel receive payments from pharmaceutical companies?
Yes. Dr. Mandel received a total of $11,535 from 45 companies across 422 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mandel's costs compare to other dermatopathology physicians in New York?
Dr. Mandel's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mandel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatopathology Physicians in New York
Browse dermatopathology physicians in New York ranked by procedure volume and transparency data.
Highest volume
Top Dermatopathology Physicians in NY
Dermatopathology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatopathology Physicians in NY
Which NY dermatopathology physicians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
MERZ NORTH AMERICA, INC. Payments to Doctors
See all physicians who received payments from MERZ NORTH AMERICA, INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology